Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging

By Yong Guo, You-quan Cai, Z. Cai, Yuanyuan Gao, N. An, Lin Ma, S. Mahankali, Jia-Hong Gao. Journal of Magnetic Resonance Imaging, 2002

770 citations recorded by the source corpus.

Subfields: Cancer Research, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/ed5387f59d8081675174003529ec44142505d281

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Peter L. Choyke

In Radiology, Nuclear Medicine and Imaging

1. B. Taouli
2. Dow-Mu Koh
3. Anwar R. Padhani
4. Thomas L. Chenevert

Citations in the corpus

• Diffusion-weighted MRI in the body: applications and challenges in oncology. (2007, background): “Elsewhere, the ADCs of malignant breast lesions have been found to be lower than the ADCs associated with benign diseases [6, 38, 39], and DWI was able to distinguish cystic soft-tissue sarcomas from solid types [40].”
• Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. (2009, result): “In line with these findings, reduced ADC values of malignant breast tumors compared with those of benign lesions and normal tissue have also been noted [16,24,25].”